跳到主要內容
:::

曾敬仁

新北市立土城醫院 核子醫學科 主任

核子醫學科

■一般核子醫學檢查與核醫功能性檢查: 腦部與中樞神經系統、心肺與呼吸循環系統、腎臟泌尿系統、腸胃道系統、未明原因之發炎與感染(蜂窩組織炎、骨髓炎)檢查、癌症與惡性轉移檢查。 ■正子掃描與分子影像: 特定癌症與惡性腫瘤：攝護腺癌、腦腫瘤、原發性肺癌、淋巴癌、黑色素癌、乳癌、甲狀腺癌、子宮頸癌之分期評估、治療前後評估及懷疑復發或再分期。 非腫瘤部份：如存活心肌偵測、癲癇病灶術前評估、未明原因之發炎與感染(蜂窩組織炎、骨髓炎)檢查。 ■核醫治療相關諮詢。 ■功能性影像\整合性影像分析。 ■臨床研究專案合作。

教職 : 副教授

醫師網路掛號

※直接點選進入醫師網路掛號畫面※

語言

  • 國語,英語,閩南語

現職

  • 新北市立土城醫院 核子醫學科 主任
  • 新北市立土城醫院核子醫學科副教授級主治醫師

學歷

  • 長庚大學 醫學影像暨放射科學系博士

經歷

  • 台北長庚紀念醫院核子醫學科主治醫師
  • 林口長庚紀念醫院核子醫學科主治醫師

學會與認證

  • 中華民國核醫學學會

論文及期刊發表

  • 王欣寧, 蘇柏榮, 邵翊紘, 吳俊德, 馮思中, 曾敬仁. 對於轉移性去勢抵抗性攝護腺癌在接受鐳 223 之後接受鎦-177 治療關於安全性及臨床結果的台灣首先經驗。Annals of Nuclear Medicine and Molecular Imaging. 2024;37:138-147.
  • Tseng JR, Hsu CL, Hsieh HH, Ho KC, Chung YH, Wu CY. The synergy of 177Lu-FAPI-46 with tyrosine kinase inhibitor in a sarcoma patient-derived xenograft mouse model. Biomedical Journal. 2024 June, Issue 3, Volume 47.
  • 陳芓安, 林嘉嘉, 楊鶴廷, 王欣寧, 曾敬仁. 使用門控式心肌灌注單光子電腦斷層掃描評估小心臟受檢者左心室射出分率：比較傳統式SPECT與MyoSPECT。Annals of Nuclear Medicine and Molecular Imaging. 2024;37:12-20.
  • 張思瀚, 劉豐源, 曾敬仁. PSMA 正子掃描對於攝護腺癌診療之應用。Annals of Nuclear Medicine and Molecular Imaging 2023;36:24-33.
  • Tran VT, Tu SJ , Tseng JR. 68Ga-PSMA-11 PET/CT Features Extracted from Different Radiomic Zones Predict Response to Androgen Deprivation Therapy in Patients with Advanced Prostate Cancer. Cancers 2022, 14, 4838.
  • Tseng JR, Chang SH, Wu YY, Fan KH, Yu KJ, Yang LY, Hsiao IT, Liu FY, Pang ST. Impact of Three-Month Androgen Deprivation Therapy on [68Ga]Ga-PSMA-11 PET/CT Indices in Men with Advanced Prostate Cancer-Results from a Pilot Prospective Study. Cancers (Basel). 2022 Mar 4;14(5):1329.
  • Tsai HC, Ho KC, Chen SH, Tseng JR, Yang LY, Lin KJ, Cheng JC, Liou MJ. Feasibility of Recombinant Human TSH as a Preparation for Radioiodine Therapy in Patients with Distant Metastases from Papillary Thyroid Cancer: Comparison of Long-Term Survival Outcomes with Thyroid Hormone Withdrawal. Diagnostics (Basel). 2022 Jan 17;12(1):221.
  • Liu FY, Sheng TW, Tseng JR, Yu KJ, Tsui KH, Pang ST, Wang LJ, Lin G. Prostate-specific membrane antigen (PSMA) fusion imaging in prostate cancer: PET-CT vs PET-MRI. Br J Radiol. 2021 Dec 21;20210728.
  • Liu FY, Lin G, Tseng JR, Chao A , Huang HJ, Chou HH, Chang YC, Yen TC, Lai CH. Measuring Heterogeneity in 18F?Fluorodeoxyglucose Positron Emission Tomography Images for Classifying Metastatic and Benign Bone Lesions in Patients with Cervical Cancer. Journal of Medical and Biological Engineering (2021) 41:924–933.�
  • Chao CH, Chu CC, Wei YC, Tseng JR, Chang HS. Anti-GABAB receptor encephalitis associated with combined small cell lung carcinoma. J Neuroimmunol. 2021 Nov 15;360:577705.
  • Tu SJ, Tran VT, Teo JM, Chong WC, Tseng JR. Utility of radiomic zones for risk classification and clinical outcome predictions using supervised machine learning during simultaneous 11 C-choline PET/MRI acquisition in prostate cancer patients. Med Phys. 2021 Sep;48(9):5192-5201.
  • Tseng JR, Yu KJ, Liu FY, Yang LY, Hong JH, Yen TC, Pang ST, Wang LJ. Comparison between 68Ga-PSMA-11 PET/CT and multiparametric magnetic resonance imaging in patients with biochemically recurrent prostate cancer following robot-assisted radical prostatectomy. J Formos Med Assoc. 2021 Jan;120(1 Pt 3):688-696.
  • Chang SH, Tsai HC , Tsai HC , Ng KF, Pang ST Tseng JR. Distinct Utility of Ga-68 PSMA-11 PET/CT and F-18 FDG PET/CT in a Patient Diagnosed With Double Cancer Cancers. Annals of Nuclear Medicine and Molecular Imaging 2020;33:50-55.
  • 吳怡君, 曾敬仁, 陳世欣, 姚正祥. [68Ga]PSMA注射劑的製造及品質檢驗。Annals of Nuclear Medicine and Molecular Imaging 2020;33:56-57.
  • 曾敬仁, 陳世欣, 姚正祥, 閻紫宸. Ga-68 PSMA PET在攝護腺癌的臨床應用。Annals of Nuclear Medicine and Molecular Imaging 2020;33:58-61.
  • Wei YC, Tseng JR, Wu CL, Su FC, Weng WC, Hsu CC, Chang KH, Wu CF, Hsiao IT, Lin CP. Different FDG-PET metabolic patterns of anti-AMPAR and anti-NMDAR encephalitis: Case report and literature review. Brain Behav. 2020 Mar;10(3):e01540.
  • Tseng JR, Chang YH, Yang LY, Wu CT, Chen SY, Wan CH, Hsiao IT, Yen TC. Potential usefulness of 68Ga-citrate PET/CT in detecting infected lower limb prostheses. EJNMMI Res. 2019 Jan 3;9(1):2.
  • Tsai HY, Lee MH, Wan CH, Yang LY, Yen TC, Tseng JR. C-reactive protein levels can predict positive 18F-FDG PET/CT findings that lead to management changes in patients with bacteremia. J Microbiol Immunol Infect. 2018 Dec;51(6):839-846.
  • Tseng JR, Yang LY, Lin YC, Liu CY, Pang ST, Hong JH, Yen TC, Wang LJ. Metabolic Volumetric Parameters in 11C-Choline PET/MR Are Superior PET Imaging Biomarkers for Primary High-Risk Prostate Cancer. Contrast Media Mol Imaging. 2018 Nov 5;2018:8945130.
  • Wan CH, Tseng JR, Lee MH, Yang LY, Yen TC. Clinical utility of FDG PET/CT in acute complicated pyelonephritis-results from an observational study. Eur J Nucl Med Mol Imaging. 2018 Mar;45(3):462-470.
  • Tseng JR, Lin CW, Chen SH, Yen TH, Lin PY, Lee MH, Yen TC. Clinical Usefulness of 1?F-FDG PET/CT for the Detection of Infections of Unknown Origin in Patients Undergoing Maintenance Hemodialysis. J Nucl Med. 2015 May;56(5):681-7.�
  • Tseng JR, Su YY, Lee MH, Chen KY, Tsai SF, Yen TC. Clinical usefulness of FDG PET/CT in the detection of unusual central nervous system infections. J Neurol Sci. 2014 Oct 15;345(1-2):244-7.
  • Tseng JR, Ho TY, Lin CY, Lee LY, Wang HM, Liao CT, Yen TC. Clinical outcomes of patients with oral cavity squamous cell carcinoma and retropharyngeal lymph node metastasis identified by FDG PET/CT. PLoS One. 2013 Nov 11;8(11):e79766.
  • Tseng JR, Chen KY, Lee MH, Huang CT, Wen YH, Yen TC. Potential usefulness of FDG PET/CT in patients with sepsis of unknown origin. PLoS One. 2013 Jun 11;8(6):e66132.
  • Tseng JR, Lee MJ, Lin JL, Yen TH. Definite and probable septic pericarditis in hemodialysis. Ren Fail. 2010;32(10):1177-82.
  • Tseng JR, Lee MJ, Yen KC, Weng CH, Liang CC, Wang IK, Chang CT, Lin-Tan DT, Lin JL, Yen TH. Course and outcome of dialysis pericarditis in diabetic patients treated with maintenance hemodialysis. Kidney Blood Press Res. 2009;32(1):17-23.
回列表

地址

236新北市土城區金城路二段6號

電話

02-2263-0588

傳真

02-2273-2688

24 小時人工智能掛號／手機掛號

412-8808／(02)412-8808

長庚醫院智能服務 有任何問題隨時找我！
:::
通過AA無障礙網頁檢測

Copyright © 2020 長庚醫療財團法人 . 未經許可不得轉載，侵權必究 法律責任

依政府法律規定: 禁止任何網際網路服務業者轉錄本網路資訊之內容供人點閱。 但以網路搜尋或超連結方式,進入本醫療機構之網址(域)直接點閱者,不在此限。